Delgocitinib
Spécifications
1263774-59-9Numéro CAS
849-957-3Numéro CE
3-[(3S,4R)-3-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrileNom IUPAC
C16H18N6OFormule chimique
310.35 g/molMasse molaire
Delgocitinib; 1263774-59-9; JTE-052; Corectim; JTE-052A; LEO 124249A; LEO 124249; LEO-124249A; delgocitinibum; LEO-124249; 9L0Q8KK220; CHEBI:167600; DTXSID401336933; 3-((3S,4R)-3-Methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl)-3-oxopropanenitrile; 3-[(3S,4R)-3-methyl-6-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile; 1,6-Diazaspiro(3.4)octane-1-propanenitrile, 3-methyl-beta-oxo-6-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-, (3S,4R)-; 3-((3S,4R)-3-methyl-6-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1,6-diazaspiro(3.4)octan-1-yl)-3-oxopropanenitrile; 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile; 1,6-Diazaspiro[3.4]octane-1-propanenitrile, 3-methyl-beta-oxo-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3S,4R)-; RefChem:585671; DTXCID201767239; 849-957-3; Anzupgo; 3-[(3S,4R)-3-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile; Delgocitinib [USAN]; 3-[(3S,4R)-3-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxidanylidene-propanenitrile; Delgocitinib?; Corectim (TN); Anzupgo (TN); ent-60; DELGOCITINIB [INN]; DELGOCITINIB [JAN]; DELGOCITINIB [WHO-DD]; UNII-9L0Q8KK220; Delgocitinib (JAN/USAN/INN); GTPL9619; JTE052; orb1308395; CHEMBL4297507; SCHEMBL12547007; SCHEMBL29360818; YQF2710; EX-A5577; BDBM50545650; MFCD31630732; AKOS040741622; AT24880; LEO-124249;JTE-052; AC-38203; BD178539; MS-24514; HY-109053; CS-0031558; D11046; T15096; 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)- 1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile; 3-[(3S,4R)-3-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxo-propanenitrile; FHXSynonymes
